Withania somnifera extracts induced attenuation of HIV-1: a mechanistic approach to restrict viral infection
Jadaun P, Harshithkumar R, Gaikwad SY, Seniya C, Borse S, Gawai AA, Chavan-Gautam P, Tillu G, Mukherjee A
Virology journal · 10 citas
Etiquetas de revisión
Solo mecanismosDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Estudio in vitro o de mecanismos (clasificado por nuestro filtro de IA)
- Estudiado en
- Células o muestras de laboratorio
- Resultado principal
- Solo mecanismos
Quién lo pagó
- Financiación
- Financiación independiente
- Gobierno
- Indian Council of Medical Research
- Gobierno
- Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy
- Universidad u hospital
- Savitribai Phule Pune University
- Gobierno
- Department of Health Research, India
- Subvenciones
- Department of Health Research, India (WSS/2020/000023/AP_WSS)
Según 4 financiadores declarados y la declaración de financiación del texto completo.
Publicación
- Publicado
- 2023-08-03 · Virol J · vol. 20 · número 1 · pág. 173
- Editorial
- BioMed Central
- Citado
- 14 citas · más que el 94% de estudios similares · 4.4× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 53 trabajos
- Acceso
- Acceso abierto (revista) · CC-BY
- Áreas de investigación
- Phytochemicals and Medicinal Plants · HIV Research and Treatment · Biological Research and Disease Studies
- Palabras clave
- Withania somnifera, Biology, Reverse transcriptase, Viral replication, Cytotoxicity, Pharmacology, Virology, Integrase, Virus, Docking (animal), In vitro, Medicinal plants, Traditional medicine, Human immunodeficiency virus (HIV), Biochemistry, Medicine, Polymerase chain reaction, Botany
- MeSH
- leukocytes, mononuclear, humans, hiv-1, withania, plants, medicinal, virus diseases, plant extracts, anti-retroviral agents, molecular docking simulation
9 autores
- Pratiksha Jadaun🇮🇳National AIDS Research Institute
- R Harshithkumar🇮🇳National AIDS Research Institute
- Shraddha Gaikwad🇮🇳National AIDS Research Institute
- Chandrabhan Seniya🇮🇳Rajiv Gandhi Technical University; VIT Bhopal University; Barkatullah University
- Swapnil Borse🇮🇳Savitribai Phule Pune University
- Ashish A Gawai
- Preeti Chavan🇮🇳Savitribai Phule Pune University
- Girish Tillu🇮🇳Savitribai Phule Pune University
- Anupam Mukherjee🇮🇳National AIDS Research Institute
Resumen
El texto original del estudio, en el idioma en que se publicó.
Background
Several anti-retroviral drugs are available against Human immunodeficiency virus type-1, but have multiple adverse side effects. Hence, there is an incessant compulsion for effectual anti-retroviral agents with minimal or no intricacy. Traditionally, natural products have been the most successful source for the development of new medications. Withania somnifera, also known as Ashwagandha, is the utmost treasured medicinal plant used in Ayurveda, which holds the potential to give adaptogenic, immunomodulatory, and antiviral effects. However, its effect on HIV-1 replication at the cellular level has never been explored. Herein, we focused on the anti-HIV-1 activity and the probable mechanism of action of hydroalcoholic and aqueous extracts of Withania somnifera roots and its phytomolecules.
Methods
The cytotoxicity of the extracts was determined through MTT assay, while the in vitro anti-HIV-1 activity was assessed in TZM-bl cells against the HIV-1 strains of X4 and R5 subtypes. Results were confirmed in peripheral blood mononuclear cells, using the HIV-1 p24 antigen assay. Additionally, the mechanism of action was determined through the Time of Addition assay, which was further validated through the series of enzymatic assays, i.e. HIV-1 Integrase, Reverse transcriptase, and Protease assays. To explore the role of the identified active metabolites of Withania somnifera in antiretroviral activity, molecular docking analyses were performed against these key HIV-1 replication enzymes.
Results
The hydroalcoholic and aqueous extracts of Withania somnifera roots were found to be safer at the sub-cytotoxic concentrations and exhibited their ability to inhibit replication of two primary isolates of HIV-1 through cell-associated and cell-free assays, in dose-dependent kinetics. Several active phytomolecules found in Withania somnifera successfully established hydrogens bonds in the active binding pocket site residues responsible for the catalytic activity of HIV replication and therefore, signifying their role in the attenuation of HIV-1 infection as implied through the in silico molecular docking studies.
Conclusions
Our research identified both the hydroalcoholic and aqueous extracts of Withania somnifera roots as potent inhibitors of HIV-1 infection. The in silico analyses also indicated the key components of Withania somnifera with the highest binding affinity against the HIV-1 Integrase by 12-Deoxywithastramonolide and 27-Hydroxywithanone, HIV-1 Protease by Ashwagandhanolide and Withacoagin, and HIV-1 Reverse transcriptase by Ashwagandhanolide and Withanolide B, thereby showing possible mechanisms of HIV-1 extenuation. Overall, this study classified the role of Withania somnifera extracts and their active compounds as potential agents against HIV-1 infection.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.